SiMPLInext SA acts in the field of advanced cell culture. Current conventional tissue models are unreliable to the point that they cannot be used as in vivo testing replacement. SiMPLInext provides a drop in replacement cell culture insert, which radically enhances the reliability, relevance, reproducibility, scope and quality of data acquired using in vitro models of biological barriers. Our inserts allow to culture better biological barriers, they allow to quality control their function in situ, and they collect the in situ measured data. This allows toxicologists and drug designers to better understand their biological barriers, without impacting processes or protocols.
| Website | http://simplinext.com |
| Revenue | $3 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2016 |
| Phone | +41 78 682 32 34 |
| Technologies |
JavaScript
,
HTML
,
PHP
+5 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Health Care, Business Services |
| Keywords | Cell Culture, Tissue Engineering, In Vitro Models, 3d Cell Culture, Cell-Based Assays, Drug Discovery, Biotechnology, Regenerative Medicine, Pharmaceutical Research, Biopharmaceutical, Life Sciences, Cell Culture Technology, In Vivo Testing, Preclinical Testing, Biological Research, Lab Equipment, Scientific Instruments, Bioprocessing |
| Competitors | PayPal, Stripe, Zuora, Chargebee, Recurly, BillingPlatform, Braintree, Aria Systems, Fusebill +41 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular SiMPLInext SA employee's phone or email?
The SiMPLInext SA annual revenue was $3 million in 2026.
Silvia Angeloni is the CEO and founder of SiMPLInext SA.
1 people are employed at SiMPLInext SA.
The NAICS codes for SiMPLInext SA are [54, 541, 5417].
The SIC codes for SiMPLInext SA are [873, 87].